Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
Search Results

Search by objective public record fields.

Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.

Clear filters
ClinicalTrials.gov public records Last synced Sep 5, 2026, 11:59 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 53 matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
Filters: Condition: Post-operative Voiding Clear all
Not yet recruiting Phase 4 Interventional

Suzetrigine for Opioid-Sparing Postoperative Analgesia Following Transvaginal Pelvic Reconstructive Surgery

NCT07600697
View directory record Official record
Conditions
Pelvic Organ Prolapse (POP), Stress Urinary Incontinence (SUI), Postoperative Pain
Interventions
Suzetrigine, Opioid Analgesics (Tramadol or Oxycodone), Scheduled Acetaminophen and Ibuprofen
Drug
Lead sponsor
University of California, Los Angeles
Other
Eligibility
18 Years and older · Female only
Enrollment
120 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2026 – 2028
U.S. locations
1
States / cities
Los Angeles, California
Source: ClinicalTrials.gov public record
Updated Jun 1, 2026 · Synced Sep 5, 2026, 11:59 AM EDT
Terminated Not applicable Interventional Accepts healthy volunteers

At Home Early vs. Delayed Catheter Removal Following Failed Postoperative Voiding Trial: a Randomized Trial

NCT05353400
View directory record Official record
Conditions
Urinary Retention Postoperative
Interventions
Early urinary catheter removal, Urinary catheter removal on POD 3
Other
Lead sponsor
Wake Forest University Health Sciences
Other
Eligibility
18 Years and older · Female only
Enrollment
9 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2022 – 2023
U.S. locations
1
States / cities
Charlotte, North Carolina
Source: ClinicalTrials.gov public record
Updated May 5, 2023 · Synced Sep 5, 2026, 11:59 AM EDT
Completed Phase 3 Interventional Accepts healthy volunteers Results available

Chlorhexidine vs. Iodine for Vaginal Preparation in Urogynecologic Procedures

NCT04048356
View directory record Official record
Conditions
Pelvic Organ Prolapse, Urinary Incontinence, Pelvic Floor Disorders, Gynecologic Disease, Post-Op Infection, Surgical Site Infection, Urinary Tract Infections
Interventions
Vaginal scrub, to be applied vaginally and perineally immediately prior to surgery.
Drug
Lead sponsor
University of New Mexico
Other
Eligibility
18 Years and older · Female only
Enrollment
137 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2019 – 2021
U.S. locations
1
States / cities
Albuquerque, New Mexico
Source: ClinicalTrials.gov public record
Updated Jul 9, 2023 · Synced Sep 5, 2026, 11:59 AM EDT
Not listed Not applicable Interventional

Impact of Integrated Care Pathways for Prevention of Post-operative Urinary Retention (POUR)

NCT03863743
View directory record Official record
Conditions
Arthroplasty, Replacement, Hip, Arthroplasty, Replacement, Knee, Urinary Retention
Interventions
integrated care pathway, physician's standard of care
Other
Lead sponsor
TriHealth Inc.
Other
Eligibility
18 Years and older
Enrollment
164 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2019 – 2022
U.S. locations
2
States / cities
Cincinnati, Ohio
Source: ClinicalTrials.gov public record
Updated Feb 28, 2021 · Synced Sep 5, 2026, 11:59 AM EDT
Completed Not applicable Interventional Accepts healthy volunteers Results available

Treatment for Acute Postoperative Voiding Dysfunction

NCT01189136
View directory record Official record
Conditions
Urinary Retention
Interventions
PTNS Active Treatment, Sham treatment
Device · Other
Lead sponsor
Women and Infants Hospital of Rhode Island
Other
Eligibility
18 Years to 95 Years · Female only
Enrollment
84 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2006 – 2013
U.S. locations
1
States / cities
Providence, Rhode Island
Source: ClinicalTrials.gov public record
Updated Feb 22, 2017 · Synced Sep 5, 2026, 11:59 AM EDT
Recruiting Phase 4 Interventional Accepts healthy volunteers

Impact of Preoperative Opioid-free Multimodal Analgesia on Time to Trial of Void in Ambulatory Urogynecologic Surgeries

NCT06379425
View directory record Official record
Conditions
Pain, Postoperative, Postoperative Pain, Acute
Interventions
Acetaminophen, Celecoxib, Gabapentin
Drug
Lead sponsor
Northwell Health
Other
Eligibility
Female only
Enrollment
70 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2024 – 2026
U.S. locations
1
States / cities
Bay Shore, New York
Source: ClinicalTrials.gov public record
Updated May 21, 2025 · Synced Sep 5, 2026, 11:59 AM EDT
Terminated Phase 4 Interventional Results available

The Effect of Tamsulosin on Postoperative Urinary Retention

NCT04682366
View directory record Official record
Conditions
Urinary Retention
Interventions
Tamsulosin, Placebo
Drug
Lead sponsor
Wake Forest University Health Sciences
Other
Eligibility
21 Years to 99 Years · Female only
Enrollment
4 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2021 – 2022
U.S. locations
1
States / cities
Winston-Salem, North Carolina
Source: ClinicalTrials.gov public record
Updated Jan 30, 2024 · Synced Sep 5, 2026, 11:59 AM EDT
Completed Phase 2Phase 3 Interventional Accepts healthy volunteers Results available

Tamsulosin vs Placebo to Prevent Postoperative Urinary Retention in Female Pelvic Reconstructive Surgery

NCT03524339
View directory record Official record
Conditions
Urinary Retention, Lower Urinary Tract Symptoms, Stress Urinary Incontinence, Pelvic Organ Prolapse
Interventions
Placebo oral capsule, Tamsulosin
Drug
Lead sponsor
University Hospitals Cleveland Medical Center
Other
Eligibility
18 Years and older · Female only
Enrollment
132 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2018 – 2020
U.S. locations
2
States / cities
Cleveland, Ohio
Source: ClinicalTrials.gov public record
Updated Nov 7, 2021 · Synced Sep 5, 2026, 11:59 AM EDT
Recruiting Not applicable Interventional

Outcomes of Limited Postoperative Restrictions Following Sling Placement: A Randomized Controlled Trial

NCT06840093
View directory record Official record
Conditions
Postoperative Restriction, Midurethral Sling, Mesh, Stress Urinary Incontinence
Interventions
Limited Restrictions, Standard Restrictions
Behavioral
Lead sponsor
University of Iowa
Other
Eligibility
18 Years to 99 Years · Female only
Enrollment
84 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2025 – 2027
U.S. locations
1
States / cities
Iowa City, Iowa
Source: ClinicalTrials.gov public record
Updated Mar 31, 2025 · Synced Sep 5, 2026, 11:59 AM EDT
Terminated No phase listed Observational

Postop Catheterization for Urinary Retention

NCT04030377
View directory record Official record
Conditions
Urinary Retention
Interventions
Not listed
Lead sponsor
Endeavor Health
Other
Eligibility
18 Years and older · Female only
Enrollment
47 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2010 – 2015
U.S. locations
1
States / cities
Skokie, Illinois
Source: ClinicalTrials.gov public record
Updated Jul 23, 2019 · Synced Sep 5, 2026, 11:59 AM EDT
Completed Not applicable Interventional

Optimal Duration of Post-Operative Activity Restriction After Midurethral Sling Procedures

NCT04817839
View directory record Official record
Conditions
Urinary Stress Incontinence
Interventions
3-week post-operative activity restriction, 6-week post-operative activity restriction
Behavioral
Lead sponsor
Yale University
Other
Eligibility
18 Years and older · Female only
Enrollment
206 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2021 – 2024
U.S. locations
1
States / cities
New Haven, Connecticut
Source: ClinicalTrials.gov public record
Updated Feb 3, 2026 · Synced Sep 5, 2026, 11:59 AM EDT
Withdrawn Not applicable Interventional

Accuracy of Bladder Scanners in Post-operative Voiding Trials

NCT03028753
View directory record Official record
Conditions
Pelvic Floor Disorders
Interventions
Bladder scan post void residual, Straight catheter post void residual, Back fill voiding trial
Device · Procedure
Lead sponsor
Tufts Medical Center
Other
Eligibility
18 Years and older · Female only
Healthy volunteers
Healthy volunteers not accepted
Timeline
2016 – 2019
U.S. locations
1
States / cities
Boston, Massachusetts
Source: ClinicalTrials.gov public record
Updated Mar 8, 2020 · Synced Sep 5, 2026, 11:59 AM EDT
Recruiting Not applicable Interventional

The Effectiveness of Prophylactic Antibiotics for Urethral Bulking

NCT06261736
View directory record Official record
Conditions
Stress Urinary Incontinence, Postoperative Urinary Tract Infection, Urethral Bulking
Interventions
Prophylactic antibiotics, No antibiotics
Other
Lead sponsor
Atlantic Health System
Other
Eligibility
18 Years and older · Female only
Enrollment
70 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2023 – 2026
U.S. locations
1
States / cities
Morristown, New Jersey
Source: ClinicalTrials.gov public record
Updated Apr 7, 2025 · Synced Sep 5, 2026, 11:59 AM EDT
Recruiting Phase 3 Interventional

Peri-operative Tamsulosin and Impact on Voiding Trial After Same-day Urogynecology Surgery

NCT06843538
View directory record Official record
Conditions
Postoperative Urinary Retention (POUR)
Interventions
Tamsulosin, Placebo
Drug
Lead sponsor
TriHealth Inc.
Other
Eligibility
18 Years and older · Female only
Enrollment
166 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2025 – 2026
U.S. locations
1
States / cities
Cincinnati, Ohio
Source: ClinicalTrials.gov public record
Updated Feb 24, 2025 · Synced Sep 5, 2026, 11:59 AM EDT
Completed Not applicable Interventional Accepts healthy volunteers

Strict Need to Void After Same-day Discharge, Non-urogynecologic, Minimally Invasive Hysterectomy

NCT05108506
View directory record Official record
Conditions
Urinary Retention Postoperative
Interventions
No Strict need to void following surgery, Strict need to void following surgery
Behavioral
Lead sponsor
Johns Hopkins University
Other
Eligibility
18 Years and older · Female only
Enrollment
205 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2022 – 2024
U.S. locations
1
States / cities
Baltimore, Maryland
Source: ClinicalTrials.gov public record
Updated Jul 16, 2024 · Synced Sep 5, 2026, 11:59 AM EDT
Terminated No phase listed Observational Accepts healthy volunteers

Voiding Dysfunction in the Postoperative Period Following Placement of the TVT

NCT00713908
View directory record Official record
Conditions
Voiding Dysfunction
Interventions
Not listed
Lead sponsor
University of Rochester
Other
Eligibility
18 Years and older · Female only
Enrollment
2 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2007 – 2009
U.S. locations
1
States / cities
Rochester, New York
Source: ClinicalTrials.gov public record
Updated Dec 15, 2009 · Synced Sep 5, 2026, 11:59 AM EDT
Not listed Not applicable Interventional Accepts healthy volunteers

Optimization of Spontaneous Postoperative Trial of Void Among Women

NCT04010656
View directory record Official record
Conditions
Urinary Retention Postoperative, Voiding Disorders
Interventions
PVR-based self-catheterization
Procedure
Lead sponsor
Women and Infants Hospital of Rhode Island
Other
Eligibility
18 Years and older · Female only
Enrollment
183 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2018 – 2021
U.S. locations
1
States / cities
Providence, Rhode Island
Source: ClinicalTrials.gov public record
Updated Jul 19, 2021 · Synced Sep 5, 2026, 11:59 AM EDT
Recruiting Early Phase 1 Interventional

Post Operative Urinary Retention (POUR) Following Thoracic Oncological Surgery

NCT05657990
View directory record Official record
Conditions
Urinary Retention
Interventions
Tamsulosin
Drug
Lead sponsor
Hackensack Meridian Health
Other
Eligibility
55 Years and older · Male only
Enrollment
46 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2023 – 2026
U.S. locations
4
States / cities
Brick, New Jersey • Manahawkin, New Jersey • Neptune City, New Jersey + 1 more
Source: ClinicalTrials.gov public record
Updated Feb 9, 2026 · Synced Sep 5, 2026, 11:59 AM EDT
Withdrawn No phase listed Observational Accepts healthy volunteers

Optimal Management of Urinary Catheter in Gyn Onc

NCT05538273
View directory record Official record
Conditions
Urinary Retention
Interventions
Early removal of urinary catheter postoperatively, Late removal of urinary catheter postoperatively
Other
Lead sponsor
WellSpan Health
Other
Eligibility
18 Years and older · Female only
Healthy volunteers
Accepts healthy volunteers
Timeline
2022 – 2023
U.S. locations
1
States / cities
York, Pennsylvania
Source: ClinicalTrials.gov public record
Updated Mar 16, 2023 · Synced Sep 5, 2026, 11:59 AM EDT
Not listed Phase 4 Interventional

Hernia Surgery Urinary Retention

NCT03027115
View directory record Official record
Conditions
Hernia, Urinary Retention
Interventions
Tamsulosin
Drug
Lead sponsor
Memorial Health University Medical Center
Other
Eligibility
18 Years and older · Male only
Enrollment
140 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2017 – 2020
U.S. locations
1
States / cities
Savannah, Georgia
Source: ClinicalTrials.gov public record
Updated Mar 22, 2018 · Synced Sep 5, 2026, 11:59 AM EDT
Completed Not applicable Interventional Results available

Randomized Control Trial to Assess Postoperative Pain After Sling Placement

NCT00746863
View directory record Official record
Conditions
Stress Urinary Incontinence
Interventions
0.125% Marcaine
Drug
Lead sponsor
University of North Carolina, Chapel Hill
Other
Eligibility
18 Years and older · Female only
Enrollment
42 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2007 – 2009
U.S. locations
1
States / cities
Chapel Hill, North Carolina
Source: ClinicalTrials.gov public record
Updated Jun 21, 2010 · Synced Sep 5, 2026, 11:59 AM EDT
Completed No phase listed Observational

Does the Presence of Preoperative Proteinuria Predict Postoperative Acute Kidney Injury in Obese Patients Undergoing Elective Laparoscopic Surgery?

NCT02798042
View directory record Official record
Conditions
Acute Kidney Injury, Obesity, Proteinuria
Interventions
Urine Sample
Other
Lead sponsor
NYU Langone Health
Other
Eligibility
18 Years to 80 Years
Enrollment
1,434 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2016 – 2023
U.S. locations
1
States / cities
New York, New York
Source: ClinicalTrials.gov public record
Updated Jul 25, 2024 · Synced Sep 5, 2026, 11:59 AM EDT
Not listed No phase listed Observational Accepts healthy volunteers

Transgender Post-reassignment Urogynecologic Measures and Perceptions

NCT03293771
View directory record Official record
Conditions
Gender Identity Disorder of Adult, Voiding Disorders, Sexual Dysfunction
Interventions
Focus group interviews, Questionnaire packet
Other · Diagnostic Test
Lead sponsor
Weill Medical College of Cornell University
Other
Eligibility
18 Years and older · Male only
Enrollment
200 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2017 – 2019
U.S. locations
1
States / cities
New York, New York
Source: ClinicalTrials.gov public record
Updated Apr 22, 2019 · Synced Sep 5, 2026, 11:59 AM EDT
Active, not recruiting No phase listed Observational Accepts healthy volunteers

NMBA Reversal and Postoperative Urinary Retention

NCT06948409
View directory record Official record
Conditions
Neuromuscular Blocking Agents, Urinary Retention After Procedure, Urinary Retention Postoperative, Neuromuscular Blockade Reversal Agent, Neuromuscular Blockade, Costs, Atropine, Sugammadex, Glycopyrrolate, Neostigmine, Anesthesia
Interventions
Choice of reversal agent (sugammadex or neostigmine [with muscaranic antagonist])
Drug
Lead sponsor
Beth Israel Deaconess Medical Center
Other
Eligibility
18 Years and older
Enrollment
70,000 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2025 – 2026
U.S. locations
1
States / cities
Boston, Massachusetts
Source: ClinicalTrials.gov public record
Updated Jan 22, 2026 · Synced Sep 5, 2026, 11:59 AM EDT